Matisse Capital’s Ascendis Pharma ASND Stock Holding History

Matisse Capital’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.82M	Sell	27,942 -1,732	-6%	-$299K	2.28%	4
2025 Q1	$4.62M	Sell	29,674 -822	-3%	-$128K	2.44%	4
2024 Q4	$4.2M	Sell	30,496 -3,188	-9%	-$439K	2.13%	4
2024 Q3	$5.03M	Sell	33,684 -1,045	-3%	-$156K	2.45%	4
2024 Q2	$4.74M	Sell	34,729 -811	-2%	-$111K	2.34%	4
2024 Q1	$5.37M	Buy	35,540 +905	+3%	+$137K	2.58%	5
2023 Q4	$4.36M	Buy	34,635 +8,380	+32%	+$1.06M	2.32%	5
2023 Q3	$2.46M	Sell	26,255 -5,695	-18%	-$533K	1.74%	6
2023 Q2	$2.85M	Buy	31,950 +3,800	+13%	+$339K	1.77%	7
2023 Q1	$3.02M	Sell	28,150 -2,370	-8%	-$254K	1.95%	5
2022 Q4	$3.73M	Buy	30,520 +5,110	+20%	+$624K	3.31%	4
2022 Q3	$2.62M	Hold	25,410	–	–	3.33%	4
2022 Q2	$2.36M	Buy	25,410 +600	+2%	+$55.8K	2.24%	4
2022 Q1	$2.91M	Buy	24,810 +970	+4%	+$114K	2.68%	5
2021 Q4	$3.21M	Buy	23,840 +3,930	+20%	+$529K	2.22%	8
2021 Q3	$3.17M	Buy	19,910 +820	+4%	+$131K	1.17%	25
2021 Q2	$2.51M	Sell	19,090 -1,100	-5%	-$145K	0.79%	42
2021 Q1	$2.6M	Buy	20,190 +2,730	+16%	+$352K	0.75%	46
2020 Q4	$2.91M	Buy	17,460 +1,300	+8%	+$217K	0.9%	42
2020 Q3	$2.49M	Buy	16,160 +2,500	+18%	+$386K	1%	39
2020 Q2	$2.02M	Buy	13,660 +1,500	+12%	+$222K	0.67%	53
2020 Q1	$1.37M	Buy	12,160 +1,200	+11%	+$135K	0.54%	56
2019 Q4	$1.53M	Buy	10,960 +430	+4%	+$59.8K	1.08%	35
2019 Q3	$1.01M	Buy	10,530 +500	+5%	+$48.1K	1.25%	26
2019 Q2	$1.16M	Sell	10,030 -100	-1%	-$11.5K	1.47%	22
2019 Q1	$1.19M	Buy	10,130 +3,400	+51%	+$400K	1.44%	25
2018 Q4	$422K	Sell	6,730 -4,600	-41%	-$288K	0.53%	45
2018 Q3	$803K	Sell	11,330 -2,970	-21%	-$210K	0.72%	45
2018 Q2	$951K	Buy	14,300 +5,200	+57%	+$346K	0.75%	36
2018 Q1	$595K	Sell	9,100 -2,990	-25%	-$196K	0.36%	71
2017 Q4	$484K	Buy	12,090 +3,500	+41%	+$140K	0.22%	80
2017 Q3	$311K	Hold	8,590	–	–	0.15%	92
2017 Q2	$238K	Buy	+8,590	New	+$238K	0.12%	102